Sleep disorders and the prevalence of asymptomatic nocturnal acid and non-acid reflux

被引:0
作者
Herdman, Christine [1 ]
Halegoua-De Marzio, Dina [1 ]
Shah, Paurush [2 ]
Denuna-Rivera, Susie [1 ]
Doghramji, Karl [3 ]
Cohen, Sidney [1 ]
DiMarino, Anthony J. [1 ]
机构
[1] Thomas Jefferson Univ, Div Gastroenterol & Hepatol, 132 South 10th St,Suite 480, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dep Internal Med, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Sleep Disorders Ctr, Dept Psychiat & Human Behav, Philadelphia, PA 19107 USA
来源
ANNALS OF GASTROENTEROLOGY | 2013年 / 26卷 / 03期
关键词
Gastro-esophageal reflux; nocturnal acid reflux; non-acid reflux; sleep disorders; insomnia;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Nocturnal acid reflux is associated with symptomatic and asymptomatic sleep arousals, leading to fragmented sleep. The frequency and influence of acid reflux in patients with various forms of insomnia has not been reported. The aim of this study was to quantify nocturnal acid and nonacid reflux in patients with primary sleep disorders as previously diagnosed by polysomnography. Methods Thirty one subjects were studied: (A) 9 subjects with a polysomnographically diagnosed sleep disorder (1 with restless legs syndrome, 4 with narcolepsy, 4 with periodic limb movement disorder); (B) 12 subjects with primary insomnia (PI) and unrevealing polysomnography; and (C) 10 controls without disturbed sleep. All subjects underwent a physical examination and 24 h transnasal pH and impedance monitoring to detect acid and non-acid reflux. Results The 21 subjects with fragmented sleep due to a primary sleep disorder had significantly more recumbent acid exposure (> 1.2% of time) as compared with control subjects (33% versus 0%). When fragmented sleep subjects were divided into two groups, 17% of PI subjects and 55% of subjects with a diagnosed sleep disorder had significant recumbent acid exposure (P= 0.009). Likewise, the median recumbent nonacid events were increased in the sleep disordered group (P= 0.011). Conclusions This study indicates that patients with primary sleep disorders have prominent nocturnal acid reflux without symptoms of daytime acid reflux. Acid reflux is most prominent in patients with polysomnographic findings of disturbed sleep as compared to patients with PI; while non acid reflux is increased minimally in these patients.
引用
收藏
页码:220 / 225
页数:6
相关论文
共 26 条
[1]   Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis [J].
Adachi, K ;
Fujishiro, H ;
Katsube, T ;
Yuki, M ;
Ono, M ;
Kawamura, A ;
Rumi, MAK ;
Watanabe, M ;
Kinoshita, Y .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (11) :1191-1196
[2]  
American Academy of Sleep Medicine (AASM), 2005, INT CLASSIFICATION S
[3]  
[Anonymous], 2005, SLEEP, V28, P1049
[4]   Validation of the Insomnia Severity Index as an outcome measure for insomnia research [J].
Bastien, Celyne H. ;
Vallieres, Annie ;
Morin, Charles M. .
SLEEP MEDICINE, 2001, 2 (04) :297-307
[5]  
Carlsson R, 1998, SCAND J GASTROENTERO, V33, P1023
[6]  
Dickman R, 2007, J CLIN SLEEP MED, V3, P505
[7]   The effect of gastro-oesophageal reflux and omeprazole on key sleep parameters [J].
Dimarino, AJ ;
Banwait, KS ;
Eschinger, E ;
Greenberg, A ;
Dimarino, M ;
Doghramji, K ;
Cohen, S .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (04) :325-329
[8]   The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life [J].
Farup, C ;
Kleinman, L ;
Sloan, S ;
Ganoczy, D ;
Chee, E ;
Lee, C ;
Revicki, D .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (01) :45-52
[9]   Effect of Zolpidem on the Sleep Arousal Response to Nocturnal Esophageal Acid Exposure [J].
Gagliardi, Gregg S. ;
Shah, Ashish P. ;
Goldstein, Mara ;
Denua-Rivera, Susie ;
Doghramji, Karl ;
Cohen, Sidney ;
Dimarino, Anthony J., Jr. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (09) :948-952
[10]   Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors [J].
Gerson, LB ;
Boparai, V ;
Ullah, N ;
Triadafilopoulos, G .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (06) :637-643